Regulation of androgen receptor levels: Implications for prostate cancer progression and therapy

Journal of Cellular Biochemistry

Volumn 95, Issue 4, 2005, Pages 657-669

  Burnstein, Kerry L ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Androgen response elements; Androgen independence; Autoregulation; Degradation; Proteasome; Steroid receptor; Transcription

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; CELL NUCLEUS RECEPTOR; LIGAND; MESSENGER RNA; TESTOSTERONE; TRANSCRIPTION FACTOR;

ADVANCED CANCER; ANDROGEN SYNTHESIS; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CELL SPECIFICITY; CONTROLLED STUDY; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN TISSUE; METASTASIS; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROSTATE CANCER; RECURRENT CANCER; REGULATORY MECHANISM; RELAPSE; REVIEW; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; ANIMAL; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION;

EID: 24744471465     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20460     Document Type: Review

References (117)

1. Balk SP. 2002. Androgen receptor as a target in androgen-independent prostate cancer. Urology 60:132-138; discussion 138-139.
2. Berger R, Febbo PG, Majumder PK, Zhao JJ, Mukherjee S, Signoretti S, Campbell KT, Sellers WR, Roberts TM, Loda M, Golub TR, Hahn WC. 2004. Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells. Cancer Res 64:8867-8875.
3. Black BE, Vitto MJ, Gioeli D, Spencer A, Afshar N, Conaway MR, Weber MJ, Paschal BM. 2004. Transient, ligand-dependent arrest of the androgen receptor in subnuclear foci alters phosphorylation and coactivator interactions. Mol Endocrinol 18:834-850.
4. Blok LJ, Themmen AP, Peters AH, Trapman J, Baarends WM, Hoogerbrugge JW, Grootegoed JA. 1992. Transcriptional regulation of androgen receptor gene expression in Sertoli cells and other cell types. Mol Cell Endocrinol 88: 153-164.
5. Bonkhoff H, Stein U, Remberger K. 1994. The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 24:114-118.
6. Burnstein KL, Jewell CM, Cidlowski JA. 1990. Human glucocorticoid receptor cDNA contains sequences sufficient for receptor down-regulation. J Biol Chem 265:7284-7291.
7. Burnstein KL, Maiorino CA, Dai JL, Cameron DJ. 1995. Androgen and glucocorticoid regulation of androgen receptor cDNA expression. Mol Cell Endocrinol 115: 177-186.
8. Chen S, Supakar PC, Vellanoweth RL, Song CS, Chatterjee B, Roy AK. 1997. Functional role of a conformationally flexible homopurine/homopyrimidine domain of the androgen receptor gene promoter interacting with Sp1 and a pyrimidine single strand DNA-binding protein. Mol Endocrinol 11:3-15.
9. Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R, Rosenfeld MG, Sawyers CL. 2004. Molecular determinants of resistance to antiandrogen therapy. Nat Med 10: 33-39.
10. Culig Z, Hobisch A, Bartsch G, Klocker H. 2000. Expression and function of androgen receptor in carcinoma of the prostate. Microsc Res Tech 51:447-455.
11. Dai JL, Burnstein KL. 1996. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA. Mol Endocrinol 10:1582-1594.
12. Dai JL, Maiorino CA, Gkonos PJ, Burnstein KL. 1996. Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells. Steroids 61:531-539.
13. DeFranco DB. 1999. Regulation of steroid receptor sub-cellular trafficking. Cell Biochem Biophys 30:1-24.
14. Delfino FJ, Boustead JN, Fix C, Walker WH. 2003. NF-kappaB and TNF-alpha stimulate androgen receptor expression in Sertoli cells. Mol Cell Endocrinol 201:1-12.
15. Eder IE, Culig Z, Ramoner R, Thurnher M, Putz T, Nessler-Menardi C, Tiefenthaler M, Bartsch G, Klocker H. 2000. Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides. Cancer Gene Ther 7:997-1007.
16. Faber PW, van Rooij HC, Schipper HJ, Brinkmann AO, Trapman J. 1993. Two different, overlapping pathways of transcription initiation are active on the TATA-less human androgen receptor promoter. The role of Sp1. J Biol Chem 268:9296-9301.
17. Feldman BJ, Feldman D. 2001. The development of androgen-independent prostate cancer. Nat Rev Cancer 1:34-45.
18. Freedman ML, Pearce CL, Penney KL, Hirschhorn JN, Kolonel LN, Henderson BE, Altshuler D. 2005. Systematic evaluation of genetic variation at the androgen receptor locus and risk of prostate cancer in a multiethnic cohort study. Am J Hum Genet 76:82-90.
19. Gao J, Arnold JT, Isaacs JT. 2001. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells. Cancer Res 61:5038-5044.
20. Gelmann EP. 2002. Molecular biology of the androgen receptor. J Clin Oncol 20:3001-3015.
21. Gioeli D, Ficarro SB, Kwiek JJ, Aaronson D, Hancock M, Catling AD, White FM, Christian RE, Settlage RE, Shabanowitz J, Hunt DF, Weber MJ. 2002. Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. J Biol Chem 277:29304-29314.
22. Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Dahl D, Brufsky A, Talcott J, Hennekens CH, Kantoff PW. 1997. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 94:3320-3323.
23. Grad JM, Dai JL, Wu S, Burnstein KL. 1999. Multiple androgen response elements and a Myc consensus site in the androgen receptor (AR) coding region are involved in androgen-mediated up-regulation of AR messenger RNA. Mol Endocrinol 13:1896-1911.
24. Gregory CW, Hamil KG, Kim D, Hall SH, Pretlow TG, Mohler JL, French FS. 1998. Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. Cancer Res 58:5718-5724.
25. Gregory CW, Johnson RT, Jr., Mohler JL, French FS, Wilson EM. 2001. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Cancer Res 61:2892-2898.
26. Grossmann ME, Tindall DJ. 1995. The androgen receptor is transcriptionally suppressed by proteins that bind single-stranded DNA. J Biol Chem 270:10968-10975.
27. Han G, Foster BA, Mistry S, Buchanan G, Harris JM, Tilley WD, Greenberg NM. 2001. Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer. J Biol Chem 276:11204-11213.
28. Han G, Buchanan G, Ittmann M, Harris JM, Yu X, Demayo FJ, Tilley W, Greenberg NM. 2005. Mutation of the androgen receptor causes oncogenic transformation of the prostate. Proc Natl Acad Sci USA 102: 1151-1156.
29. Hardy DO, Scher HI, Bogenreider T, Sabbatini P, Zhang ZF, Nanus DM, Catterall JF. 1996. Androgen receptor CAG repeat lengths in prostate cancer: Correlation with age of onset. J Clin Endocrinol Metab 81:4400-4405.
30. He B, Wilson EM. 2002. The NH(2)-terminal and carboxyl-terminal interaction in the human androgen receptor. Mol Genet Metab 75:293-298.
31. Heinlein CA, Chang C. 2002a. Androgen receptor (AR) coregulators: An overview. Endocr Rev 23:175-200.
32. Heinlein CA, Chang C. 2002b. The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol Endocrinol 16:2181-2187.
33. Heinlein CA, Chang C. 2004. Androgen receptor in prostate cancer. Endocr Rev 25:276-308.
34. Hellerstedt BA, Pienta KJ. 2002. The current state of hormonal therapy for prostate cancer. CA Cancer J Clin 52:154-179.
35. Hobisch A, Culig Z, Radmayr C, Bartsch G, Klocker H, Hittmair A. 1995. Distant metastases from 4rostatic carcinoma express androgen receptor protein. Cancer Res 55:3068-3072.
36. Huss WJ, Maddison LA, Greenberg NM. 2001. Autochthonous mouse models for prostate cancer: Past, present and future. Semin Cancer Biol 11:245-260.
37. Igawa T, Lin FF, Lee MS, Karan D, Batra SK, Lin MF. 2002. Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model. Prostate 50:222-235.
38. Isomaa V, Parvinen M, Janne OA, Bardin CW. 1985. Nuclear androgen receptors in different stages of the seminiferous epithelial cycle and the interstitial tissue of rat testis. Endocrinology 116:132-137.
39. Kaneko KJ, Furlow JD, Gorski J. 1993. Involvement of the coding sequence for the estrogen receptor gene in autologous ligand-dependent down-regulation. Mol Endocrinol 7:879-888.
40. Kang Z, Pirskanen A, Janne OA, Palvimo JJ. 2002. Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J Biol Chem 277:48366-48371.
41. Kemppainen JA, Lane MV, Sar M, Wilson EM. 1992. Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. J Biol Chem 267:968-974.
42. Ko YJ, Devi GR, London CA, Kayas A, Reddy MT, Iversen PL, Bubley GJ, Balk SP. 2004. Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers. J Urol 172:1140-1144.
43. Kokontis JM, Liao S. 1999. Molecular action of androgen in the normal and neoplastic prostate. Vitam Horm 55:219-307.
44. Kokontis J, Takakura K, Hay N, Liao S. 1994. Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation. Cancer Res 54:1566-1573.
45. Kokontis JM, Hay N, Liao S. 1998. Progression of LNCaP prostate tumor cells during androgen deprivation: Hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest. Mol Endocrinol 12:941-953.
46. Krongrad A, Wilson CM, Wilson JD, Allman DR, McPhaul MJ. 1991. Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells. Mol Cell Endocrinol 76:79-88.
47. Lange CA, Shen T, Horwitz KB. 2000. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc Natl Acad Sci USA 97:1032-1037.
48. Langley E, Zhou ZX, Wilson EM. 1995. Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. J Biol Chem 270:29983-29990.
49. Lin HK, Altuwaijri S, Lin WJ, Kan PY, Collins LL, Chang C. 2002a. Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells. J Biol Chem 277:36570-36576.
50. Lin HK, Wang L, Hu YC, Altuwaijri S, Chang C. 2002b. Phosphorylation- dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J 21:4037-4048.
51. Lu S, Tsai SY, Tsai MJ. 1999. Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells. Endocrinology 140:5054-5059.
52. Magi-Galluzzi C, Xu X, Hlatky L, Hahnfeldt P, Kaplan I, Hsiao P, Chang C, Loda M. 1997. Heterogeneity of androgen receptor content in advanced prostate cancer. Mod Pathol 10:839-845.
53. Manin M, Baron S, Goossens K, Beaudoin C, Jean C, Veyssiere G, Verhoeven G, Morel L. 2002. Androgen receptor expression is regulated by the phosphoinositide 3-kinase/Akt pathway in normal and tumoral epithelial cells. Biochem J 366:729-736.
54. Marker PC, Donjacour AA, Dahiya R, Cunha GR. 2003. Hormonal, cellular, and molecular control of prostatic development. Dev Biol 253:165-174.
55. Martinez ED, Danielsen M. 2002. Loss of androgen receptor transcriptional activity at the G(1)/S transition. J Biol Chem 277:29719-29729.
56. McPhaul MJ, Deslypere JP, Allman DR, Gerard RD. 1993. The adenovirus-mediated delivery of a reporter gene permits the assessment of androgen receptor function in genital skin fibroblast cultures. Stimulation of Gs and inhibition of G(o). J Biol Chem 268:26063-26066.
57. Mellinghoff IK, Tran C, Sawyers CL. 2002. Growth inhibitory effects of the dual ErbB1/ErbB2 tyrosine kinase inhibitor PKI-166 on human prostate cancer xenografts. Cancer Res 62:5254-5259.
58. Mellinghoff IK, Vivanco I, Kwon A, Tran C, Wongvipat J, Sawyers CL. 2004. HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability. Cancer Cell 6:517-527.
59. Mizokami A, Chang C. 1994. Induction of translation by the 5′-untranslated region of human androgen receptor mRNA. J Biol Chem 269:25655-25659.
60. Mizokami A, Yeh SY, Chang C. 1994. Identification of 3′,5′- cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter. Mol Endocrinol 8:77-88.
61. Mohler JL, Gregory CW, Ford OH3rd, Kim D, Weaver CM, Petrusz P, Wilson EM, French FS. 2004. The androgen axis in recurrent prostate cancer. Clin Cancer Res 10: 440-448.
62. Mora GR, Mahesh VB. 1999. Autoregulation of the androgen receptor at the translational level: Testosterone induces accumulation of androgen receptor mRNA in the rat ventral prostate polyribosomes. Steroids 64:587-591.
63. Narayanan BA, Narayanan NK, Pittman B, Reddy BS. 2004. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model. Clin Cancer Res 10:7727-7737.
64. Nastiuk KL, Clayton DF. 1994. Seasonal and tissue-specific regulation of canary androgen receptor messenger ribonucleic acid. Endocrinology 134:640-649.
65. Nawaz Z, O'Malley BW. 2004. Urban renewal in the nucleus: is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription? Mol Endocrinol 18:493-499.
66. Nawaz Z, Lonard DM, Dennis AP, Smith CL, O'Malley BW. 1999. Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci USA 96:1858-1862.
67. Prins GS. 1992. Neonatal estrogen exposure induces lobe-specific alterations in adult rat prostate androgen receptor expression. Endocrinology 130:3703-3714.
68. Prins GS, Birch L. 1993. Immunocytochemical analysis of androgen receptor along the ducts of the separate rat prostate lobes after androgen withdrawal and replacement. Endocrinology 132:169-178.
69. Prins GS, Birch L. 1995. The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to estrogen. Endocrinology 136:1303-1314.
70. Prins GS, Woodham C. 1995. Autologous regulation of androgen receptor messenger ribonucleic acid in the separate lobes of the rat prostate gland. Biol Reprod 53: 609-619.
71. Prins GS, Woodham C, Lepinske M, Birch L. 1993. Effects of neonatal estrogen exposure on prostatic secretory genes and their correlation with androgen receptor expression in the separate prostate lobes of the adult rat. Endocrinology 132:2387-2398.
72. Prins GS, Jung MH, Vellanoweth RL, Chatterjee B, Roy AK. 1996. Age-dependent expression of the androgen receptor gene in the prostate and its implication in glandular differentiation and hyperplasia. Dev Genet 18: 99-106.
73. Quarmby VE, Yarbrough WG, Lubahn DB, French FS, Wilson EM. 1990. Autologous down-regulation of androgen receptor messenger ribonucleic acid. Mol Endocrinol 4:22-28.
74. Rajfer J, Coffey DS. 1978. Sex steroid imprinting of the immature prostate. Long-term effects. Invest Urol 16: 186-190.
75. Roy AK, Lavrovsky Y, Song CS, Chen S, Jung MH, Velu NK, Bi BY, Chatterjee B. 1999. Regulation of androgen action. Vitam Horm 55:309-352.
76. Ruizeveld de Winter JA, Janssen PJ, Sleddens HM, Verleun-Mooijman MC, Trapman J, Brinkmann AO, Santerse AB, Schroder FH, van der Kwast TH. 1994. Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Am J Pathol 144:735-746.
77. Saccani S, Pantano S, Natoli G. 2003. Modulation of NF-kappaB activity by exchange of dimers. Mol Cell 11: 1563-1574.
78. Santos AF, Huang H, Tindall DJ. 2004. The androgen receptor: A potential target for therapy of prostate cancer. Steroids 69:79-85.
79. Shah RB, Mehra R, Chinnaiyan AM, Shen R, Ghosh D, Zhou M, Macvicar GR, Varambally S, Harwood J, Bismar TA, Kim R, Rubin MA, Pienta KJ. 2004. Androgen-independent prostate cancer is a heterogeneous group of diseases: Lessons from a rapid autopsy program. Cancer Res 64:9209-9216.
80. Shan LX, Rodriguez MC, Janne OA. 1990. Regulation of androgen receptor protein and mRNA concentrations by androgens in rat ventral prostate and seminal vesicles and in human hepatoma cells. Mol Endocrinol 4:1636-1646.
81. Sheflin L, Keegan B, Zhang W, Spaulding SW. 2000. Inhibiting proteasomes in human HepG2 and LNCaP cells increases endogenous androgen receptor levels. Biochem Biophys Res Commun 276:144-150.
82. Sobel RE, Sadar MD. 2005a. Cell lines used in prostate cancer research: A compendium of old and new lines-Part 1. J Urol 173:342-359.
83. Sobel RE, Sadar MD. 2005b. Cell lines used in prostate cancer research: A compendium of old and new lines-Part 2. J Urol 173:360-372.
84. Solit DB, Zheng FF, Drobnjak M, Munster PN, Higgins B, Verbel D, Heller G, Tong W, Cordon-Cardo C, Agus DB, Scher HI, Rosen N. 2002. 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts. Clin Cancer Res 8:986-993.
85. Song CS, Jung MH, Supakar PC, Chatterjee B, Roy AK. 1999. Negative regulation of the androgen receptor gene promoter by NFI and an adjacently located multiprotein-binding site. Mol Endocrinol 13:1487-1496.
86. Stanbrough M, Leav I, Kwan PW, Bubley GJ, Balk SP. 2001. Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium. Proc Natl Acad Sci USA 98:10823-10828.
87. Supakar PC, Song CS, Jung MH, Slomczynska MA, Kim JM, Vellanoweth RL, Chatterjee B, Roy AK. 1993. A novel regulatory element associated with age-dependent expression of the rat androgen receptor gene. J Biol Chem 268:26400-26408.
88. Supakar PC, Jung MH, Song CS, Chatterjee B, Roy AK. 1995. Nuclear factor kappa B functions as a negative regulator for the rat androgen receptor gene and NF-kappa B activity increases during the age-dependent desensitization of the liver. J Biol Chem 270:837-842.
89. Sweeney C, Li L, Shanmugam R, Bhat-Nakshatri P, Jayaprakasan V, Baldridge LA, Gardner T, Smith M, Nakshatri H, Cheng L. 2004. Nuclear factor-kappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate. Clin Cancer Res 10: 5501-5507.
90. Syms AJ, Norris JS, Panko WB, Smith RG. 1985. Mechanism of androgen-receptor augmentation. Analysis of receptor synthesis and degradation by the density-shift technique. J Biol Chem 260:455-461.
91. Takane KK, McPhaul MJ. 1996. Functional analysis of the human androgen receptor promoter. Mol Cell Endocrinol 119:83-93.
92. Takane KK, Husmann DA, McPhaul MJ, Wilson JD. 1991a. Androgen receptor levels in the rat penis are controlled differently in distinctive cell types. Endocrinology 128: 2234-2238.
93. Takane KK, Wilson JD, McPhaul MJ. 1991b. Decreased levels of the androgen receptor in the mature rat phallus are associated with decreased levels of androgen receptor messenger ribonucleic acid. Endocrinology 129:1093-1100.
94. Takeda H, Nakamoto T, Kokontis J, Chodak GW, Chang C. 1991. Autoregulation of androgen receptor expression in rodent prostate: Immunohistochemical and in situ hybridization analysis. Biochem Biophys Res Commun 177:488-496.
95. Takeuchi M, Kakushi H, Tohkin M. 1994. Androgens directly stimulate mineralization and increase androgen receptors in human osteoblast-like osteosarcoma cells. Biochem Biophys Res Commun 204:905-911.
96. Tan JA, Joseph DR, Quarmby VE, Lubahn DB, Sar M, French FS, Wilson EM. 1988. The rat androgen receptor: Primary structure, autoregulation of its messenger ribonucleic acid, and immunocytochemical localization of the receptor protein. Mol Endocrinol 2:1276-1285.
97. Taplin ME, Balk SP. 2004. Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence. J Cell Biochem 91:483-490.
98. Tilley WD, Marcelli M, McPhaul MJ. 1990. Expression of the human androgen receptor gene utilizes a common promoter in diverse human tissues and cell lines. J Biol Chem 265:13776-13781.
99. Tsai MJ, O'Malley BW. 1994. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451-486.
100. Umekita Y, Hiipakka RA, Kokontis JM, Liao S. 1996. Human prostate tumor growth in athymic mice: Inhibition by androgens and stimulation by finasteride. Proc Natl Acad Sci USA 93:11802-11807.
101. van der Kwast TH, Schalken J, Ruizeveld de Winter JA, van Vroonhoven CC, Mulder E, Boersma W, Trapman J. 1991. Androgen receptors in endocrine-therapy- resistant human prostate cancer. Int J Cancer 48:189-193.
102. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi OP. 1995. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 9:401-406.
103. Vornberger W, Prins G, Musto NA, Suarez-Quian CA. 1994. Androgen receptor distribution in rat testis: New implications for androgen regulation of spermatogenesis. Endocrinology 134:2307-2316.
104. Wallace AD, Cidlowski JA. 2001. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J Biol Chem 276: 42714-42721.
105. Wang LG, Ossowski L, Ferrari AC. 2004. Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line. Oncogene 23:5175-5184.
106. Wiren KM, Zhang X, Chang C, Keenan E, Orwoll ES. 1997. Transcriptional up-regulation of the human androgen receptor by androgen in bone cells. Endocrinology 138: 2291-2300.
107. Wolf DA, Herzinger T, Hermeking H, Blaschke D, Horz W. 1993. Transcriptional and posttranscriptional regulation of human androgen receptor expression by androgen. Mol Endocrinol 7:924-936.
108. Woodham C, Birch L, Prins GS. 2003. Neonatal estrogen down-regulates prostatic androgen receptor through a proteosome-mediated protein degradation pathway. Endocrinology 144:4841-4850.
109. Wright ME, Tsai MJ, Aebersold R. 2003. Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells. Mol Endocrinol 17:1726-1737.
110. Wu HC, Hsieh JT, Gleave ME, Brown NM, Pathak S, Chung LW. 1994. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: Role of bone stromal cells. Int J Cancer 57:406-412.
111. Yeap BB, Krueger RG, Leedman PJ. 1999. Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells. Endocrinology 140:3282-3291.
112. Yeap BB, Voon DC, Vivian JP, McCulloch RK, Thomson AM, Giles KM, Czyzyk-Krzeska MF, Furneaux H, Wilce MC, Wilce JA, Leedman PJ. 2002. Novel binding of HuR and poly(C)-binding protein to a conserved UC-rich motif within the 3′-untranslated region of the androgen receptor messenger RNA. J Biol Chem 277:27183-27192.
113. Zeegers MP, Kiemeney LA, Nieder AM, Ostrer H. 2004. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk? Cancer Epidemiol Biomarkers Prev 13:1765-1771.
114. Zegarra-Moro OL, Schmidt LJ, Huang H, Tindall DJ. 2002. Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Res 62:1008-1013.
115. Zhang L, Charron M, Wright WW, Chatterjee B, Song CS, Roy AK, Brown TR. 2004. Nuclear factor-kappaB activates transcription of the androgen receptor gene in Sertoli cells isolated from testes of adult rats. Endocrinology 145:781-789.
116. Zhong H, May MJ, Jimi E, Ghosh S. 2002. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 9:625-636.
117. Zhou ZX, Lane MV, Kemppainen JA, French FS, Wilson EM. 1995. Specificity of ligand-dependent androgen receptor stabilization: Receptor domain interactions influence ligand dissociation and receptor stability. Mol Endocrinol 9:208-218.